XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 70,482 $ 103,172
Accounts receivable, less allowance of $1,024 and $973, respectively 196,616 185,058
Inventory:    
Raw materials 64,871 64,175
Work in process 13,807 16,139
Finished goods 41,959 41,095
Inventory, net 120,637 121,409
Derivative financial instruments 1,168 213
Prepaid expenses and other assets 56,848 51,217
Total current assets 445,751 461,069
Property and equipment, net 205,232 200,294
Goodwill 70,439 69,685
Other intangible assets, net 80,809 83,286
Deferred financing costs 875 936
Deferred income tax assets 84,946 30,152
Other non-current assets 13,371 37,983
Total assets 901,423 883,405
Current Liabilities:    
Accounts payable 88,087 89,596
Accrued liabilities 72,908 77,209
Current maturities of long-term debt 3,485 3,460
Derivative financial instruments 1 1,050
Total current liabilities 164,481 171,315
Pension benefit obligation 7,965 7,913
Other liabilities 6,759 2,747
Long-term debt, less current maturities 105,742 141,209
Deferred income tax liabilities 6,028 6,347
Total liabilities 290,975 329,531
Common Stock:    
No par value; 55,000,000 shares authorized, 36,794,573 and 36,761,362 issued and outstanding at March 31, 2018 and December 31, 2017, respectively 266,812 265,048
Paid-in capital 16,155 15,625
Accumulated other comprehensive loss (7,551) (20,444)
Accumulated earnings 335,032 293,645
Total shareholders’ equity 610,448 553,874
Total liabilities and shareholders’ equity $ 901,423 $ 883,405